Genesystem Co (XKRX:363250) ROE % Adjusted to Book Value : -13.68% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co ROE % Adjusted to Book Value?

Genesystem Co's ROE % for the quarter that ended in Mar. 2024 was -32.96%. Genesystem Co's PB Ratio for the quarter that ended in Mar. 2024 was 2.41. Genesystem Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -13.68%.

Genesystem Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Genesystem Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co ROE % Adjusted to Book Value Chart

Genesystem Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

7.03

-13.77

-10.68

Genesystem Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-12.57	-4.27	-5.34	-8.98	-13.68

Competitive Comparison of Genesystem Co's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Genesystem Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genesystem Co's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genesystem Co's ROE % Adjusted to Book Value falls into.

Genesystem Co ROE % Adjusted to Book Value Calculation

Genesystem Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-25.30%	/	2.37
	=	-10.68%

Genesystem Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-32.96%	/	2.41
	=	-13.68%

Genesystem Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genesystem Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Genesystem Co (XKRX:363250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028

Website

http://www.genesystem.co.kr

Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines